ArticleFrontiers in neurology2026
Effect of intracranial pressure monitoring-based therapy on clinical efficacy and serum levels in neurosurgical patients with severe intracerebral hemorrhage.
Article in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the effect of intracranial pressure (ICP) monitoring combined with hematoma evacuation on clinical efficacy and serum markers in neurosurgical patients with severe intracerebral hemorrhage. Methods: A total of 120 patients with severe intracerebral hemorrhage treated in the Department of Neurology, Taihe Hospital, Hubei University of Medicine from January 2025 to January 2026 were retrospectively enrolled. According to whether postoperative ICP monitoring was performed, the patients were divided into an ICP monitoring group (hematoma evacuation + external ventricular drain-based ICP monitoring) and a control group (hematoma evacuation alone). Propensity score matching at a 1:1 ratio was used to balance baseline characteristics, and 57 patients were ultimately included in each group. The surgical indicators, 3-month favorable outcome defined as Glasgow Outcome Scale score 4-5, neurological deficit scores, serum levels of endothelin-1 (ET-1), matrix metalloproteinase-9 (MMP-9), advanced oxidation protein products (AOPP), cortisol (Cor), and norepinephrine (NE), activity of daily living (ADL) score, and complication rates were compared between the two groups. Results: After matching, there were no significant differences in intraoperative blood loss and evacuated hematoma volume between the two groups (both Conclusion: Intracranial pressure monitoring combined with hematoma evacuation was associated with better clinical outcome, lower serum levels of ET-1, MMP-9, AOPP, and stress hormones, fewer complications, and greater independence in daily living. However, the observational design limits causal inference, and the external ventricular drain may have contributed both monitoring and therapeutic drainage effects that cannot be completely separated in this study.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.